vs
Side-by-side financial comparison of Ceribell, Inc. (CBLL) and Crexendo, Inc. (CXDO). Click either name above to swap in a different company.
Ceribell, Inc. is the larger business by last-quarter revenue ($24.8M vs $18.1M, roughly 1.4× Crexendo, Inc.). Crexendo, Inc. runs the higher net margin — 6.7% vs -54.6%, a 61.3% gap on every dollar of revenue.
Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.
Crexendo, Inc. is a U.S.-headquartered cloud communications technology provider. It delivers unified communications as a service (UCaaS), contact center solutions, business VoIP services, and collaborative work tools, primarily catering to small and medium-sized enterprises operating in the North American market.
CBLL vs CXDO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $24.8M | $18.1M |
| Net Profit | $-13.5M | $1.2M |
| Gross Margin | 87.3% | — |
| Operating Margin | -58.9% | 6.3% |
| Net Margin | -54.6% | 6.7% |
| Revenue YoY | — | 11.2% |
| Net Profit YoY | — | 140.2% |
| EPS (diluted) | $-0.35 | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $24.8M | $18.1M | ||
| Q3 25 | $22.6M | $17.5M | ||
| Q2 25 | $21.2M | $16.6M | ||
| Q1 25 | $20.5M | $16.1M | ||
| Q4 24 | — | $16.2M | ||
| Q3 24 | $17.2M | $15.6M | ||
| Q2 24 | — | $14.7M | ||
| Q1 24 | — | $14.3M |
| Q4 25 | $-13.5M | $1.2M | ||
| Q3 25 | $-13.5M | $1.4M | ||
| Q2 25 | $-13.6M | $1.2M | ||
| Q1 25 | $-12.8M | $1.2M | ||
| Q4 24 | — | $507.0K | ||
| Q3 24 | $-10.4M | $148.0K | ||
| Q2 24 | — | $588.0K | ||
| Q1 24 | — | $434.0K |
| Q4 25 | 87.3% | — | ||
| Q3 25 | 88.3% | — | ||
| Q2 25 | 88.1% | — | ||
| Q1 25 | 87.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 87.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -58.9% | 6.3% | ||
| Q3 25 | -64.8% | 7.5% | ||
| Q2 25 | -70.5% | 6.7% | ||
| Q1 25 | -69.3% | 7.2% | ||
| Q4 24 | — | 3.9% | ||
| Q3 24 | -57.8% | 0.9% | ||
| Q2 24 | — | 3.9% | ||
| Q1 24 | — | 3.4% |
| Q4 25 | -54.6% | 6.7% | ||
| Q3 25 | -59.6% | 8.3% | ||
| Q2 25 | -64.4% | 7.4% | ||
| Q1 25 | -62.4% | 7.3% | ||
| Q4 24 | — | 3.1% | ||
| Q3 24 | -60.6% | 0.9% | ||
| Q2 24 | — | 4.0% | ||
| Q1 24 | — | 3.0% |
| Q4 25 | $-0.35 | $0.03 | ||
| Q3 25 | $-0.37 | $0.05 | ||
| Q2 25 | $-0.38 | $0.04 | ||
| Q1 25 | $-0.36 | $0.04 | ||
| Q4 24 | — | $0.03 | ||
| Q3 24 | $-1.85 | $0.00 | ||
| Q2 24 | — | $0.02 | ||
| Q1 24 | — | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $159.3M | — |
| Total DebtLower is stronger | — | $114.0K |
| Stockholders' EquityBook value | $155.3M | $63.8M |
| Total Assets | $195.8M | $77.7M |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $159.3M | — | ||
| Q3 25 | $168.5M | — | ||
| Q2 25 | $177.4M | — | ||
| Q1 25 | $182.7M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $14.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $114.0K | ||
| Q3 25 | — | $236.0K | ||
| Q2 25 | — | $356.0K | ||
| Q1 25 | — | $475.0K | ||
| Q4 24 | — | $592.0K | ||
| Q3 24 | — | $709.0K | ||
| Q2 24 | — | $823.0K | ||
| Q1 24 | — | $937.0K |
| Q4 25 | $155.3M | $63.8M | ||
| Q3 25 | $164.1M | $61.3M | ||
| Q2 25 | $172.2M | $58.3M | ||
| Q1 25 | $180.9M | $55.2M | ||
| Q4 24 | — | $51.4M | ||
| Q3 24 | $-136.0M | $49.5M | ||
| Q2 24 | — | $48.2M | ||
| Q1 24 | — | $46.8M |
| Q4 25 | $195.8M | $77.7M | ||
| Q3 25 | $199.5M | $76.0M | ||
| Q2 25 | $207.7M | $71.4M | ||
| Q1 25 | $213.5M | $67.4M | ||
| Q4 24 | — | $64.9M | ||
| Q3 24 | $47.1M | $62.3M | ||
| Q2 24 | — | $59.6M | ||
| Q1 24 | — | $57.5M |
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.01× | ||
| Q1 25 | — | 0.01× | ||
| Q4 24 | — | 0.01× | ||
| Q3 24 | — | 0.01× | ||
| Q2 24 | — | 0.02× | ||
| Q1 24 | — | 0.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.8M | $2.3M |
| Free Cash FlowOCF − Capex | $-11.0M | — |
| FCF MarginFCF / Revenue | -44.2% | — |
| Capex IntensityCapex / Revenue | 0.7% | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.93× |
| TTM Free Cash FlowTrailing 4 quarters | $-41.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-10.8M | $2.3M | ||
| Q3 25 | $-11.1M | $4.4M | ||
| Q2 25 | $-7.5M | $1.3M | ||
| Q1 25 | $-11.4M | $1.2M | ||
| Q4 24 | — | $2.2M | ||
| Q3 24 | — | $1.6M | ||
| Q2 24 | — | $2.7M | ||
| Q1 24 | — | $-166.0K |
| Q4 25 | $-11.0M | — | ||
| Q3 25 | $-11.5M | — | ||
| Q2 25 | $-7.6M | $1.3M | ||
| Q1 25 | $-11.6M | — | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -44.2% | — | ||
| Q3 25 | -50.8% | — | ||
| Q2 25 | -35.9% | 7.7% | ||
| Q1 25 | -56.4% | — | ||
| Q4 24 | — | 13.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.7% | 0.0% | ||
| Q3 25 | 1.6% | 0.0% | ||
| Q2 25 | 0.3% | 0.1% | ||
| Q1 25 | 0.7% | 0.0% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.05× | ||
| Q2 25 | — | 1.05× | ||
| Q1 25 | — | 1.06× | ||
| Q4 24 | — | 4.29× | ||
| Q3 24 | — | 10.95× | ||
| Q2 24 | — | 4.51× | ||
| Q1 24 | — | -0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
CXDO
| Services | $8.6M | 48% |
| Software Solution Segment | $8.3M | 46% |
| Products | $1.1M | 6% |
